7 research outputs found
Thermal reactions in mixtures of micron-sized silicon monoxide and titanium monoxide: redox paths overcoming passivation shells
SmÄsnĂ© oxidy a kompozity oxidu TiO2/SiO2 byly intenzivnÄ studovĂĄny, zatĂmco kekich protÄjĆĄky oxidu titanatĂ©ho (TiO) a oxidu kĆemnatĂ©ho (SiO) stĂĄle zĆŻstĂĄvajĂ neprozkoumĂĄny. Tato studie odhaluje strukturĂĄlnĂ zmÄny ve zahĆĂĄtĂœch smÄsĂch SiO-TiO. ZmÄny sloĆŸenĂ ve smĂsenĂœch mikro-ÄĂĄsticĂch TiO a SiO zahĆĂvanĂœch pĆi 1000 ° C byly zkoumĂĄny pomocĂ FTIR, UV-Vis a Ramanovy spektroskopie, rentgenovĂ© difrakce a elektronovĂ© mikroskopie (SEM a TEM). Ukazuje se, ĆŸe dochĂĄzĂ k Ășbytku krystalickĂ©ho TiO a tvorbÄ suboxidĆŻ titanu (Ti2.5O3, Ti2O3), rutilu, elementĂĄrnĂho kĆemĂku, silicidu titanu Ti5Si3 a amorfnĂch binĂĄrnĂch SiOx, TiOx a ternĂĄrnĂch nanostruktur SixTiyOz. Tvorba tohoto Si/Ti/O kompozitu je vysvÄtlena disproprciacĂ SiO, redukcĂ TiO kĆemĂkem, pĆenosem kyslĂku (redoxnĂ reakce) mezi TiOx a SiOx a kombinacĂ Ti a Si k zĂskĂĄnĂ silicidu titanu. VytvoĆenĂœ Si/Ti/O kompozit absorbuje viditelnĂ© svÄtlo a jeho fotokatalytickĂĄ aktivita ve sluneÄnĂm zĂĄĆenĂ byla testovĂĄna na odbarvovĂĄnĂ methylenovĂ© modĆi (bBlue) a porovnĂĄvĂĄna s prĂĄĆĄkem nezahĆĂĄtĂ©ho SiO, TiO a Ti5Si3.Silicaâtitania mixed oxides and composites have been extensively studied, whereas the titanium monoxide (TiO)âsilicon monoxide (SiO) counterparts still remain to be explored. Here, we report on structural changes in heated SiOâTiO mixtures. The changes in composition in intimately mixed ÎŒm-sized particles of TiO and SiO heated at 1000 °C were examined by FTIR, UVâVis and Raman spectroscopy, X-ray diffraction and electron (SEM and TEM) microscopy. They are shown to involve depletion of crystalline TiO and formation of titanium suboxides (Ti2.5O3, Ti2O3), rutile, elemental silicon, titanium silicide Ti5Si3 and amorphous binary SiOx, TiOx and ternary SixTiyOz nano-structures. These constituents of the developed Si/Ti/O composite are explained by SiO disproportionation, reduction of TiO by silicon, oxygen transfer (redox) reactions between TiOx and SiOx species and the combination of Ti and Si to obtain titanium silicide. The produced Si/Ti/O composite absorbs visible light and its solar-light photocatalytic activity in decolorization of methylene bBlue is compared to that of the unheated SiO, TiO and Ti5Si3 powders
Recent advances on smart glycoconjugate vaccines in infections and cancer
Vaccination is one of the greatest achievements in biomedical research preventing death and morbidity in many infectious diseases through the induction of pathogen-specific humoral and cellular immune responses. Currently, no effective vaccines are available for pathogens with a highly variable antigenic load, such as the human immunodeficiency virus or to induce cellular T-cell immunity in the fight against cancer. The recent SARS-CoV-2 outbreak has reinforced the relevance of designing smart therapeutic vaccine modalities to ensure public health. Indeed, academic and private companies have ongoing joint efforts to develop novel vaccine prototypes for this virus. Many pathogens are covered by a dense glycan-coat, which form an attractive target for vaccine development. Moreover, many tumor types are characterized by altered glycosylation profiles that are known as âtumor-associated carbohydrate antigensâ. Unfortunately, glycans do not provoke a vigorous immune response and generally serve as T-cell-independent antigens, not eliciting protective immunoglobulin G responses nor inducing immunological memory. A close and continuous crosstalk between glycochemists and glycoimmunologists is essential for the successful development of efficient immune modulators. It is clear that this is a key point for the discovery of novel approaches, which could significantly improve our understanding of the immune system. In this review, we discuss the latest advancements in development of vaccines against glycan epitopes to gain selective immune responses and to provide an overview on the role of different immunogenic constructs in improving glycovaccine efficacy